TriSalus Life Sciences, Inc.
corporate_fare Company Profile
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for TLSI at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- TriSalus Life Sciences Exceeds 2025 Revenue Guidance, Projects Strong 2026 Growth
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$45.15M
Net Income
-$39.23M
Diluted EPS
-$1.84
Op. Cash Flow
-$18.01M
Free Cash Flow
-$18.93M
Gross Profit
$38.19M
Operating Income
-$26.95M
Cash & Equivalents
$20.44M
Total Debt
$33.05M
Debt / Equity
-0.98×
Net Margin
-86.9%
Shares Outstanding
50M sh
Source: 10-K · filed 2026-03-05 · accession 0001628280-26-015163
show_chartPrice Chart
Loading chart...
feed TLSI - Filings & News (Page 2)
TLSI
Jan 12, 2026, 7:09 AM EST
Price at Filing:
$5.80
Real-time Price:
$2.32
Change:
-$3.48 (-60%)
Market Cap:
$143.142M